San Diego: A single treatment with gene therapy, an experimental technique for fixing faulty genes, has been shown to boost output of a vital blood clotting factor, possibly offering a long-term solution for people with hemophilia B.Researchers said the same technology was also being studied as a treatment for hemophilia A, the far more common type of the inherited bleeding disorder."It is a technique for potentially permanently curing patients," said Dr. Charles Abrams, American Society of Hematology secretary and associate chief of hematology/oncology at the University of Pennsylvania in Philadelphia.Both safety and efficacy have held back the field of gene therapy. One experiment cured two French boys with a rare immune disorder but gave them leukemia in 2002, and an Arizona teenager died in a 1999 gene therapy experiment.The approach used by researchers at the University College London Cancer Institute and St. Jude Children`s Research Hospital in Memphis, Tennessee, involved the use of a novel viral "vector," designed to target the liver specifically.
Zohra Sehgal, the grand old diva of Indian cinema
Heavy rains disrupt normal life in Mumbai
Varanasi: Three held for capturing Ganga aarti
Congress to oppose Nripendra Mishra`s appointment as Principal Secy to PM